27904 | width | saurabh | 12/23/2015 1:27:29 AM |
27903 | wry | saurabh | 12/23/2015 1:27:17 AM |
27902 | to | saurabh | 12/23/2015 1:27:02 AM |
27901 | testing | saurabh | 12/23/2015 1:26:48 AM |
27900 | HCTI Stock Chart | testuser | 12/21/2015 4:02:25 PM |
27899 | testing | testuser | 12/21/2015 12:58:51 PM |
27898 | sdffsddfs | testuser | 12/21/2015 12:35:38 PM |
27897 | dfgchc | saurabh | 12/21/2015 3:50:55 AM |
27896 | wet | saurabh | 12/21/2015 3:50:43 AM |
27895 | cgfg | saurabh | 12/21/2015 3:50:32 AM |
27894 | dfu | saurabh | 12/21/2015 3:50:16 AM |
27893 | trstt | saurabh | 12/21/2015 3:50:03 AM |
27892 | testt | saurabh | 12/21/2015 3:49:47 AM |
27891 | ghgdf | itest | 12/21/2015 1:37:05 AM |
27890 | ghdfjfj | itest | 12/21/2015 1:34:47 AM |
27889 | 3333 | testuser | 12/21/2015 1:18:46 AM |
27888 | 3333 | testuser | 12/21/2015 1:18:38 AM |
27887 | testing | testuser | 12/21/2015 1:18:30 AM |
27886 | testing211 | testuser | 12/21/2015 1:18:18 AM |
27885 | hjkmg, | itest | 12/21/2015 1:09:01 AM |
27884 | chack | itest | 12/21/2015 1:01:55 AM |
27883 | fhcg | testuser | 12/21/2015 12:15:29 AM |
27882 | test4 | testuser | 12/20/2015 11:58:46 PM |
27881 | test3 | testuser | 12/20/2015 11:58:32 PM |
27880 | test2 | testuser | 12/20/2015 11:58:18 PM |
27879 | test1 | testuser | 12/20/2015 11:58:00 PM |
27878 | testing 1 2 3 | testuser | 12/20/2015 10:45:41 PM |
27877 | testing5 | testuser | 12/19/2015 4:57:54 AM |
27876 | testing4 | testuser | 12/19/2015 4:57:38 AM |
27875 | testing3 | testuser | 12/19/2015 4:57:24 AM |
27874 | testing2 | testuser | 12/19/2015 4:57:07 AM |
27873 | testing1 | testuser | 12/19/2015 4:55:27 AM |
27872 | fdgfgdfgdgfdgdf | testuser | 12/15/2015 9:28:09 PM |
27871 | gfdgdfgd | testuser | 12/15/2015 9:28:04 PM |
27870 | dfggdfg | testuser | 12/15/2015 9:27:58 PM |
27869 | gdgffgdfg | testuser | 12/15/2015 9:27:52 PM |
27868 | gfddgfgf | testuser | 12/15/2015 9:27:48 PM |
27867 | hhgtrytrthytryrt | testuser | 11/30/2015 1:59:13 PM |
27866 | trytyytryrtyeyt | testuser | 11/30/2015 1:59:07 PM |
27865 | 3443432355345353 | testuser | 11/30/2015 1:59:02 PM |
27864 | 324434434 | testuser | 11/30/2015 1:58:56 PM |
27863 | 123 | testuser | 11/30/2015 1:58:51 PM |
27862 | test | Chas | 11/29/2015 12:29:01 AM |
27861 | dasdsad | testuser | 11/28/2015 1:03:46 AM |
27860 | sdfsdfsdfsdf | testuser | 11/28/2015 1:03:40 AM |
27859 | dfdfdfsdsfsdf | testuser | 11/28/2015 1:03:32 AM |
27858 | sdfdsfdfs | testuser | 11/28/2015 1:03:23 AM |
27857 | sdfgdsf | testuser | 11/28/2015 1:01:02 AM |
27856 | dsfdsfsfsdd | testuser | 11/25/2015 10:00:45 PM |
27855 | rgtrtreterrt | testuser | 11/25/2015 10:00:40 PM |
Recent Articles
- Insight into Novo Nordisk Share Trading by Executives
- Revolutionizing B-ALL Treatment: FDA Approves AUCATZYL for Adults
- ManpowerGroup Increases Dividend to $1.54 Per Share
- Primo Brands: A New Era in Healthy Hydration Begins
- Avanos Medical Set for Key Presentation at UBS Conference
- ePlus Sets Release Date for Q2 FY025 Financial Results
- Investigation into EMCORE and AlloVir: Are Your Rights Protected?
- Michigan Municipalities Stand Up for Local Energy Regulation Control
- Cathy W. Liles Joins Old Point Financial as CFO
- CNL Strategic Capital Reports Impressive Growth and Returns
- Bionomics Reveals Details on Re-domiciliation Plans
- Matthews International Prepares to Release Q4 2024 Earnings Soon
- Grayscale Investments Unveils Share Split Plans for ETFs
- Millicom Director Shares Sold: Impact on Investors and Market
- Esperion’s New RSU Grants Enhance Employee Commitment and Growth
- Aptose Biosciences Showcases Promising Progress this Quarter
- Replimune Expands Team with New Equity Award Grants
- electroCore Welcomes New VP with Inducement Grant Announcement
- Exploring FT836 in Cancer Therapy: Fate Therapeutics Breakthrough
- Aduro Clean Technologies Completes Successful Nasdaq Offering
- PacBio Announces Key Investor Conferences for 2024 Engagement
- AI Transportation Acquisition Corp Delays Important Shareholder Meeting
- Adams Resources & Energy, Inc. Prepares for Q3 Earnings Call
- Entera Bio's Q3 2024 Highlights: Growth in Oral Therapies
- Vera Therapeutics Prepares for Significant Investor Engagements
- Landsea Homes to Showcase Innovative Developments at Investor Conference
- FutureFuel Corp. Reports Q3 2024: Revenue Decline and Outlook
- Codexis Expands Workforce with New Inducement Grants
- Triumph Financial's Presentation at the Upcoming Investment Conference
- Important Announcement from Grupo Aeroportuario del Pacífico
- New Providence Acquisition Corp. II Moves Towards Liquidation
- Hoover Institution Launches Initiative on Immigration Issues
- Myeloid Therapeutics Gets Ready for SITC 2024 with MT-303
- Business Intelligence Market Growth Driven by AI and Trends
- Amgen's Presentation Highlights at Upcoming Health Conference
- SaferWatch Provides Real-Time Support for Poll Workers
- Pintec Technology Reports First Half 2024 Financial Performance
- Cleco Corporate Holdings Launches Tender Offer for Senior Notes
- Golden Heaven's Amusement Complex Opening Delayed for Enhancements
- Realty Income Marks Milestone with 653rd Monthly Dividend
- Cohen & Steers Updates Realty Indices for Enhanced Investing
- Aviat Networks Set to Engage Investors in Key Conferences
- Luxury Living Redefined: Parkside Apartments' Remarkable Sale
- Biglari Holdings Reports Third Quarter and First Nine Months
- Forian Inc.'s Key Participation in ROTH MKM Annual Event
- Nova Vision Acquisition Corp. Secures Trust Extension Until December
- Novo Nordisk A/S Expands Share Buyback Program with DKK 4.7 Billion
- Novo Nordisk's Share Repurchase Program: Key Insights
- CenterPoint Energy Monitoring Hurricane Rafael Developments
- AI Market Set to Surge by $237.4 Billion Amid Cybersecurity Focus